Evaluation and Management of Low TSH with High T4
A patient with suppressed TSH and elevated free T4 has overt hyperthyroidism (thyrotoxicosis) and requires immediate evaluation to determine the underlying cause, followed by definitive treatment to prevent cardiovascular complications, bone loss, and other morbidity.
Initial Diagnostic Approach
Confirm the Diagnosis
The combination of suppressed TSH (<0.01 mU/L) with elevated free T4 confirms overt hyperthyroidism 1. You must also measure total T3 or free T3 immediately, as both are typically elevated in overt disease 1.
Rule Out Euthyroid Hyperthyroxinemia First
Before proceeding with hyperthyroidism treatment, exclude non-thyrotoxic causes of elevated T4 with suppressed TSH 1:
- Protein binding disorders: TBG excess (pregnancy, estrogen, hepatitis, certain drugs like 5-fluorouracil, perphenazine), familial dysalbuminemia
- Drug effects: Amiodarone, high-dose propranolol (inhibit T4→T3 conversion)
- Assay interference: Heparin therapy causes spurious free T4 elevations, heterophilic antibodies
- Rare causes: Acute psychosis, extreme altitude, amphetamine abuse
Critical distinction: If TSH is normal or elevated with high free T4, consider TSH-producing pituitary adenoma (check pituitary MRI, alpha-subunit levels) or thyroid hormone resistance (family history, genetic testing for T3-receptor mutations) 1.
Determine the Etiology
When to Perform Radioactive Iodine Uptake (RAIU)
Perform RAIU when the clinical presentation is not clearly diagnostic of Graves' disease 1. Skip RAIU only if the patient has:
- Symmetrically enlarged thyroid
- Recent onset ophthalmopathy
- Moderate to severe hyperthyroidism
The RAIU distinguishes between:
Elevated/Normal Uptake (thyroid overproduction):
- Graves' disease (diffuse uptake)
- Toxic adenoma or toxic multinodular goiter (focal/patchy uptake)
- TSH-producing adenoma
- Trophoblastic disease
Near-Absent Uptake (thyroid inflammation/destruction):
- Painless (silent) thyroiditis
- Amiodarone-induced thyroiditis
- Subacute thyroiditis
Add a thyroid scan if nodularity is present on examination 1.
Treatment Strategy
For Graves' Disease (Most Common Cause)
Methimazole is the preferred antithyroid drug in virtually all patients, except during first trimester pregnancy (use propylthiouracil), thyroid storm, or minor methimazole reactions in patients refusing radioiodine/surgery 1.
Before starting antithyroid drugs 1:
- Obtain baseline CBC with differential and liver function tests (transaminases, bilirubin)
- Warn patients to stop medication immediately and call if they develop: rash, jaundice, pale stools, dark urine, joint pain, abdominal pain, nausea, fatigue, fever, or sore throat
Beta-blockers should be initiated immediately to control adrenergic symptoms (tachycardia, tremor, anxiety, heat intolerance) while awaiting thyroid hormone normalization 2.
Definitive Treatment Options
Three options exist for Graves' disease:
Radioactive iodine (131I): Preferred for definitive cure. Administer sufficient dose to render patient hypothyroid in a single treatment 1. If free T4 >5 ng/dL (60 pmol/L) or total T4 >20 μg/dL, pretreat with methimazole and beta-blockers until normalized 1.
Antithyroid drugs: Continue for 1-2 years. If no remission after this period, proceed to radioiodine or surgery 1.
Thyroidectomy: Total or near-total thyroidectomy by high-volume thyroid surgeon. Render euthyroid with methimazole first, add potassium iodide immediately preoperatively 1.
Monitoring After Treatment
Post-Radioiodine Follow-up
- Assess free T4 and total T3 at 1-2 months 1
- If still thyrotoxic, monitor every 4-6 weeks 1
- Most patients normalize within 4-8 weeks
- TSH remains suppressed for ≥1 month after thyroid hormones normalize—do not rely on TSH alone initially 1, 2
- If hyperthyroidism persists at 6 months or minimal response at 3 months, retreat with 131I 1
Long-term Surveillance
Once euthyroid or hypothyroid on replacement:
- Lifelong annual thyroid function testing is mandatory 1
- 5-20% may develop spontaneous hypothyroidism even without radioiodine treatment 2
Critical Pitfalls to Avoid
Do not treat transient TSH suppression in early pregnancy (hCG-mediated)—this is physiologic 1
Do not rely on TSH alone in the first 1-2 months after treatment, as it lags behind free T4/T3 normalization 1, 2
Avoid iatrogenic hypothyroidism in patients with Graves' orbitopathy, as this worsens eye disease 2
Do not miss subclinical hyperthyroidism (normal T4/T3, suppressed TSH)—treat if TSH <0.1 mU/L in patients ≥65 years, those with cardiac disease/osteoporosis, or symptomatic patients 1
Measure T3 in addition to T4—some patients have isolated T3 elevation ("T3-toxicosis"), especially in early disease or toxic nodules 1